Are you an academic researcher looking for cutting-edge drug discovery tools? Join our Academic Access Program!

HiBiT-Powered CRISPR Knock-Ins for Endogenous Tagging

One Tiny Tag, Big Impact

CRISPR/Cas9 knock-in technology coupled with the tiny, powerful HiBiT tag allows researchers to study proteins in their natural environment. By eliminating the need for overexpression or antibody-based detection, HiBiT knock-ins preserve natural regulation and provide data that is more accurate, reproducible, and biologically meaningful using simple, scalable bioluminescent-based detection. Researchers can precisely quantify protein abundance using endpoint or live-cell kinetic methods, creating a clearer view of how proteins respond under changing conditions or therapeutic compound treatment. HiBiT technology is also compatible with surface-expressed and secreted protein detection. In addition, a sensitive, high-affinity anti-HiBiT monoclonal antibody enables further use in traditional immunoassays like Western blots and immunoprecipitation, providing additional ways to analyze HiBiT knock-in cells.

Our CRISPR/Cas9 knock-in cell lines support a wide range of applications in drug discovery and functional biology, including:

  • Receptor internalization: track movement of membrane proteins and their regulation in live cells.
  • Downstream signaling: measure how protein activity influences broader pathways.
  • Targeted protein degradation: monitor degrader activity, kinetics and compound potency in real time.

Getting Started with CRISPR/Cas9 Knock-In Cell Lines

Choosing a workflow for CRISPR-enabled endogenous biology experiments will depend on the type of experiment, laboratory resources and experience, and the project timeline. Get started quickly by taking advantage of our collection of 250+ CRISPR-knock-in cell line pools and clones, available for a variety of target proteins and cell backgrounds. If you need to create custom knock-in cells, you have options. Check out the detailed protocol and access the HiBiT sequence. Need guidance? Reach out to one of our experts to ensure you get the results you need. Or, connect with a licensed service provider to explore custom knock-in cell generation options.

Choose the Path that Best Meets Your Needs

Pre-Built Cell Lines and Pools
Custom Cell Line and Pool Options
cart


 

Check out our comprehensive list of 250+ cell line pools and clones for popular targets and cell backgrounds.

View Cell Lines

tool


cart


Build it yourself

 

Use our detailed protocol to create your own HiBiT knock-in cells. Obtain the HiBiT sequence and synthesis rights and review our terms of use by completing our licensing agreement.

View Detailed Protocol

View Licensing Agreement

Connect with a licensed provider

 

Collaborate with experts who offer custom knock-in and gene-editing services:

EditCo Bio – Provides functionally validated CRISPR-edited cell lines, offering precise and scalable genome engineering solutions to support research in cell and gene therapy, drug discovery, and basic biology.

FUJIFILM CDI – Offers custom knock-in cell line generation using human iPSC-derived cells to create physiologically relevant models for disease research, drug discovery, and cell therapy development.

ALSTEM, Inc. – Delivers custom iPSCs, CRISPR/Cas9-edited cell lines, and viral vectors, supporting research in regenerative medicine, disease modeling, drug discovery, and basic biology.

Why Choose HiBiT for CRISPR Knock-In Experiments?

HiBiT knock-in tagging combines the precision of CRISPR with the sensitivity of bioluminescence. By inserting HiBiT directly into the genome, you can:

  • Monitor physiological expression to avoid gene dosage effects and artifacts from overexpression.
  • Study genes under natural promoter and epigenetic control.
  • Maintain protein balance by preserving natural ratios with interacting partners.
  • Generate knock-in models faster as no molecular cloning is required.
The Benefits of Endogenous Tagging
tagging endogenous loci using crispr knock-in method

Endogenous tagging creates an improved assay window for BRD4 degradation assay

Protein levels shift with cellular conditions or therapeutic interventions, such as protein degrader treatments, making sensitive assays essential. Here, we used a CRISPR knock-in of HiBiT at the BRD4 locus to measure protein abundance following treatment with the dBET1 degrader. BRD4 under native regulation was compared with different dilutions of CMV or TK-driven overexpression. Cells were treated with a titration of dBET1 and protein abundance was measured by quantifying the HiBiT tag (using the Nano-Glo® HiBiT Lytic Detection System). Normalized luminescence values demonstrated that the knock-in cells provided an increased assay window when compared to higher level overexpression models, highlighting the advantage of monitoring native expression.

View White Paper
14286MB

What is HiBiT Tagging?

Learn More